Amino Acids China E-News

Publication: Monthly on the
Published by CCM

Amino Acids China E-News provides you with real-time intelligence on China's amino acids market.
 
China has rapidly emerged as a leading producer of amino acids in recent years thanks to increasing demand from the country's feed and pharmaceuticals markets. However, competition in the industry is shifting as producers battle to upgrade their production technology to comply with strict new environmental regulations and create higher-margin pharmaceutical-grade products.
 
Amino Acids China E-News will help you stay ahead of the game in this fast-changing market with real-time reporting on the entire amino acid industry chain, from raw materials to end consumption. This includes:
      
  • Breaking news from China and abroad
  •   
  • The latest market data, including price information for raw materials, intermediates and end products, import/export data, production, consumption, operating rates, etc.
  •   
  • In-depth analysis of market trends, Chinese government policy, the performance of leading Chinese producers, M&A, new technologies, and more
  •   
  • Expert commentary from industry insiders, including regular guest articles and interviews with insiders at leading Chinese manufacturers, associations and government organizations
Amino Acids China E-News is also available as a monthly newsletter, which can be downloaded in PDF format. For more information, you can download a free sample below, or get in touch with us directly by emailing econtact@cnchemicals.com or calling +86-20-37616606.


  • Future-issues subscription

Starting from the issue of
202404
lasting for


0.5 1 1.5 2 2.5 3


year(s)  , is priced at


  • Single user license:
    USD 2,950.00
  • Corporate license:
    USD 7,375.00

All the prices on this website exclude VAT.

<<
  • 202404
  • 202403
  • 202402
  • 202401
  • 202312
  • 202311
  • 202310
  • 202309
  • 202308
  • 202307
  • 202306
  • 202305
  • 202304
  • 202303
  • 202302
  • 202301
  • 202212
  • 202211
  • 202210
  • 202209
  • 202208
  • 202207
  • 202206
  • 202205
  • 202204
  • 202203
  • 202202
  • 202201
  • 202112
  • 202111
  • 202110
  • 202109
  • 202108
  • 202107
  • 202106
  • 202105
  • 202104
  • 202103
  • 202102
  • 202101
  • 202012
  • 202011
  • 202010
  • 202009
  • 202008
  • 202007
  • 202006
  • 202005
  • 202004
  • 202003
  • 202002
  • 202001
  • 201912
  • 201911
  • 201910
  • 201909
  • 201908
  • 201907
  • 201906
  • 201905
  • 201904
  • 201903
  • 201902
  • 201901
  • 201812
  • 201811
  • 201810
  • 201809
  • 201808
  • 201807
  • 201806
  • 201805
  • 201804
  • 201803
  • 201802
  • 201801
  • 201712
  • 201711
  • 201710
  • 201709
  • 201708
  • 201707
  • 201706
  • 201705
  • 201704
  • 201703
  • 201702
  • 201701
  • 201612
  • 201611
  • 201610
  • 201609
  • 201608
  • 201607
  • 201606
  • 201605
  • 201604
  • 201603
  • 201602
  • 201601
  • 201512
  • 201511
  • 201510
  • 201509
  • 201508
  • 201507
  • 201506
  • 201505
  • 201504
  • 201503
  • 201502
  • 201501
  • 201412
  • 201411
  • 201410
  • 201409
  • 201408
>>

Main Content of Amino Acids China E-News 201608

Price of this issue :
USD 98

Published on 30th August, 2016

Published on 30th August, 2016

In early Aug. 2016, domestic lysine producers slightly reduced their quotations, mainly affected by the weakening demand and tightening supply. Analyst CCM predicted that this situation is likely to go on for a short term but the lysine price may rebound in the coming period.

Published on 30th August, 2016

Published on 30th August, 2016

In H1 2016, China's export volume of lysine ester & salt rose by 13% YoY, mainly supported by the low export price and the increased export to the Netherlands. Notably, H1 also saw increases in export volume of many other amino acids.

Published on 30th August, 2016

Published on 30th August, 2016

Published on 30th August, 2016

Published on 30th August, 2016

Published on 30th August, 2016

Published on 30th August, 2016

In H1 2016, Meihua Bio recorded fall in revenue but rise in net profit, affected by the falling sales prices and reduction in production costs of raw materials. Given the further decreased corn price and higher environmental pressure confronted its rivals, the company may continue enjoying favorable business development condition in the coming period, according to analyst CCM.

Published on 30th August, 2016

By-health suffered a YoY fall of 13.94% in net profit, mainly affected by the surge in brand promotion expenses. The company, focusing on developing vitamin healthcare products, has only one amino acid product. Meanwhile, it also faces fierce competition in this market.

Published on 30th August, 2016

The CFDA issued the draft of Announcement on Verification of Pharmaceutical Production Techniques to solicit public opinions on inspection towards consistency between manufacturers' actual production techniques and their registered ones. Affected by this, enterprises may face higher operating costs and those failing to change production techniques are very likely to be eliminated from the market.

Published on 30th August, 2016

In H1 2016, Fufeng Group's gross profit increased slightly, mainly thanks to the well-performed threonine and premium amino acid businesses. In the coming period, the company plans to break into the cosmetics industry through further developing its premium amino acids.

Published on 30th August, 2016

On 19 Aug., 2016, Yongan Pharmaceutical released its financial report for H1. In particular, its net profit recorded significant growth thanks to the increased sales volume and price of its leading product, taurine.

Published on 25th August, 2016

A number of feed manufacturers have predicted financial growth in H1 2016, mainly due to increased demand from the pig farming industry and owing to a larger proportion of highly profitable products being sold and low production costs of raw materials.

Published on 19th August, 2016

Adisseo announced a surge in H1 2016 net profit by 109% YoY, mainly thanks to increase of methionine production capacity, large rise in VA price and decrease in crude oil prices.

Published on 19th August, 2016

Fosun Pharma acquired the Indian pharmaceutical producer Gland for no more than USD190.26 million (RMB1.26 billion), an acquisition cost breaking record high. At present, more enterprises are marching into the rapidly developing acetylcysteine market.

CCM Customized Service on Market Research

Do you want Import & Export Analysis, Financial Data, Cost Analysis, Supply Chain Research etc. ? We will customize the specific research for you, in case the services listed above does not meet your precise requirements. Our product and industry research in China’s agriculture, chemicals, food & ingredients and life science markets will comprehensively cover the business information, which is able to help you arrive at strategic and profitable business decisions.

Please directly contact econtact@cnchemicals.com to specify your Market Research Requirement